Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost/Timolol Fixed Combination vs Travoprost in Primary Open-Angle Glaucoma
NCT00444184Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Mar 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of travoprost + timolol in primary open-angle glaucoma (POAG) (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoint: Mean 24-hour Intraocular Pressure at 3 months. Started Mar 2007; status: completed.
02
Drugs
travoprost + timolol
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT00444184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444184.